Immune Thrombocytopenia following COVID-19 Vaccine.
Journal
Case reports in hematology
ISSN: 2090-6560
Titre abrégé: Case Rep Hematol
Pays: United States
ID NLM: 101576456
Informations de publication
Date de publication:
2022
2022
Historique:
received:
09
10
2021
revised:
16
04
2022
accepted:
16
05
2022
entrez:
7
7
2022
pubmed:
8
7
2022
medline:
8
7
2022
Statut:
epublish
Résumé
Several vaccines have been developed and are being administered against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Common side effects include fever, chills, headache, myalgia, and soreness at the injection site. However, some rare adverse effects have also been reported. We present a case of induced thrombocytopenia presenting with petechiae and mucosal bleeding which developed as an adverse response after first-dose administration of the Moderna COVID-19 vaccine.
Identifiants
pubmed: 35795543
doi: 10.1155/2022/6013321
pmc: PMC9252767
doi:
Types de publication
Case Reports
Langues
eng
Pagination
6013321Informations de copyright
Copyright © 2022 Sonal Prasad et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Am J Hematol. 2021 May 1;96(5):E133-E134
pubmed: 33476455
Vaccine. 2021 Jun 8;39(25):3329-3332
pubmed: 34006408
Am J Hematol. 2021 May 1;96(5):534-537
pubmed: 33606296
Am J Hematol. 2020 Jan;95(1):38-47
pubmed: 31621093
J Blood Med. 2021 Apr 06;12:221-224
pubmed: 33854395
N Engl J Med. 2021 Oct 28;385(18):1680-1689
pubmed: 34379914
N Engl J Med. 2021 Jun 10;384(23):2202-2211
pubmed: 33861525
N Engl J Med. 2021 Jun 10;384(23):2254-2256
pubmed: 33861524